Reckon Health Care Holdings Ltd (AU:GGR)
ASX:GGR
Want to see AU:GGR full AI Analyst Report?
GGR Stock Chart & Stats
AU$0.20
--
Market closed
AU$0.20
--
Day’s Range― - ―
52-Week RangeAU$0.13 - AU$0.33
Previous CloseN/A
VolumeN/A
Average Volume (3M)299.00K
Market Cap
N/A
Enterprise ValueAU$21.50M
Total Cash (Recent Filing)AU$261.65K
Total Debt (Recent Filing)AU$389.86K
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Apr 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding140,024,220
10 Day Avg. Volume126,568
30 Day Avg. Volume298,997
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)14.06
Price to Sales (P/S)0.00
P/FCF Ratio-30.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Modest LeverageRelatively low debt (debt-to-equity ~0.33 in 2025) reduces near-term solvency and interest burden, giving management more flexibility to raise time and prioritize restructuring or product development. This durable balance-sheet attribute lowers refinancing pressure over the next several months.
Improving Cash BurnA reduction in cash burn in 2025 versus 2024 signals management progress on cost controls or operating efficiency. If sustained, this trend meaningfully extends runway, reduces near-term external funding needs, and increases the probability the business can reach a stable cash flow position within a multi-month horizon.
Very Lean Cost BaseA one-person headcount indicates an extremely lean operating structure with minimal fixed payroll overhead. That structural cost advantage reduces baseline cash consumption, enabling the company to preserve capital and reallocate limited resources toward sustaining critical activities or strategic pivots over the medium term.
Bears Say
Persistent Net LossesSustained net losses through 2021–2025 indicate structural inability to cover costs from operations. Continued losses erode shareholder equity, limit reinvestment, and make future profitability dependent on significant operational change or external funding—risks that persist beyond short-term market cycles.
Minimal Or No RevenueRevenue collapsing to minimal or zero undermines the firm's core business viability. Without a meaningful revenue base there is no platform for margin recovery or scalable economics, forcing reliance on financing or asset sales and making durable operational recovery more uncertain.
Negative Cash GenerationConsistent negative operating and free cash flow means the company consumes cash rather than generates it, increasing reliance on external capital. Over a multi-month horizon this raises dilution or refinancing risk and constrains the ability to invest in growth or fix underlying operational issues.
Reckon Health Care Holdings Ltd News
GGR FAQ
What was Reckon Health Care Holdings Ltd’s price range in the past 12 months?
Reckon Health Care Holdings Ltd lowest share price was AU$0.13 and its highest was AU$0.33 in the past 12 months.
What is Reckon Health Care Holdings Ltd’s market cap?
Currently, no data Available
When is Reckon Health Care Holdings Ltd’s upcoming earnings report date?
Reckon Health Care Holdings Ltd’s upcoming earnings report date is Apr 20, 2027 which is in 343 days.
How were Reckon Health Care Holdings Ltd’s earnings last quarter?
Currently, no data Available
Is Reckon Health Care Holdings Ltd overvalued?
According to Wall Street analysts Reckon Health Care Holdings Ltd’s price is currently Overvalued.
Does Reckon Health Care Holdings Ltd pay dividends?
Reckon Health Care Holdings Ltd does not currently pay dividends.
What is Reckon Health Care Holdings Ltd’s EPS estimate?
Reckon Health Care Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Reckon Health Care Holdings Ltd have?
Reckon Health Care Holdings Ltd has 140,024,220 shares outstanding.
What happened to Reckon Health Care Holdings Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Reckon Health Care Holdings Ltd?
Currently, no hedge funds are holding shares in AU:GGR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckon Health Care Holdings Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
Reckon Health Care Holdings Ltd
Golden Globe Resources Ltd, a minerals exploration company, focuses on identifying and developing of copper and gold assets in Australia. Its propertes holds 100% interest in the Dooloo Creek Project comprises two granted exploration permits covering 77.94 square kilometers located in Southeast Queensland, Australia; and Neila Creek Prospect comprises one exploration licence for minerals covering 42.73square kilometers located in New South Wales. The company was formerly known as Reckon Health Care Holdings Limited and changed its name to Golden Globe Resources Ltd in July 2017. Golden Globe Resources Ltd was incorporated in 2014 and is based in Sydney, Australia.